Analyst Price Targets — INSP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 4, 2026 11:59 am | — | Evercore ISI | $54.00 | $62.78 | TheFly | Inspire Medical price target raised to $54 from $40 at Evercore ISI |
| August 4, 2026 11:34 am | — | Truist Financial | $62.00 | $52.22 | TheFly | Inspire Medical price target raised to $62 from $54 at Truist |
| August 4, 2026 11:05 am | Shagun Singh | RBC Capital | $60.00 | $63.00 | StreetInsider | Inspire Medical Systems (INSP) PT Raised to $60 at RBC Capital |
| August 4, 2026 10:56 am | — | Stifel Nicolaus | $75.00 | $52.22 | TheFly | Inspire Medical price target raised to $75 from $65 at Stifel |
| August 4, 2026 10:53 am | — | Oppenheimer | $85.00 | $52.22 | TheFly | Inspire Medical upgraded to Outperform from Perform at Oppenheimer |
| August 4, 2026 10:49 am | — | Piper Sandler | $60.00 | $52.22 | TheFly | Inspire Medical price target raised to $60 from $55 at Piper Sandler |
| August 4, 2026 10:17 am | — | Robert W. Baird | $59.00 | $52.22 | TheFly | Inspire Medical price target raised to $59 from $54 at Baird |
| July 28, 2026 10:30 am | Patrick Wood | UBS | $39.00 | $50.93 | TheFly | Inspire Medical assumed with Sell from Neutral at UBS |
| July 16, 2026 2:05 pm | — | Truist Financial | $54.00 | $52.28 | TheFly | Inspire Medical price target raised to $54 from $50 at Truist |
| June 23, 2026 10:03 am | Daniel Markowitz | Evercore ISI | $40.00 | $41.35 | TheFly | Inspire Medical downgraded to In Line from Outperform at Evercore ISI |
Latest News for INSP
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.
ADAR1 Capital Management LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE: INSP) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 374,617 shares of the company's stock, valued at approximately $16,712,000. Inspire Medical Systems accounts for
Bank of America Corp DE cut its holdings in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 11.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 186,069 shares of the company's stock after selling 24,057 shares during the quarter. Bank
Deutsche Bank AG purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE: INSP) during the undefined quarter, according to the company in its most recent filing with the SEC. The fund purchased 176,200 shares of the company's stock, valued at approximately $7,860,000. Deutsche Bank AG owned about 0.61% of Inspire
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INSP.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.